comparative study on microRNA in serum and cavernous tissue of patients with refractory erectile dysfunction and controls
Not Applicable
- Conditions
- erectile dysfunction
- Registration Number
- JPRN-UMIN000020922
- Lead Sponsor
- no body
- Brief Summary
Main result already published
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- Male
- Target Recruitment
- 60
Inclusion Criteria
Not provided
Exclusion Criteria
patients suffer from erectile dysfunction (diabetics or cardiacs)
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method level of microRNA in serum and cavernous tissue in patients with refractory ED and controls
- Secondary Outcome Measures
Name Time Method potential role of microRNA as a diagnostic marker of refractory ED
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What specific miRNAs are dysregulated in refractory erectile dysfunction according to JPRN-UMIN000020922?
How do serum miRNA profiles in JPRN-UMIN000020922 correlate with PDE5 inhibitor response in ED patients?
Which miRNAs identified in JPRN-UMIN000020922 serve as biomarkers for refractory ED patient stratification?
What adverse events are associated with miRNA-targeted therapies for erectile dysfunction in clinical studies?
How do miRNA expression patterns in cavernous tissue from JPRN-UMIN000020922 inform combination therapies for ED?